U.S. Specialty Stores Stock News

NYSE:RNST
NYSE:RNSTBanks

A Look At Renasant (RNST) Valuation After Its Q4 2025 Earnings Beat And Dividend Approval

Renasant (RNST) is back on investors' radar after fourth quarter 2025 adjusted earnings per share came in above analyst forecasts, and the board also approved a quarterly dividend of $0.23 per share. See our latest analysis for Renasant. Even with the earnings beat and confirmed dividend, Renasant’s recent 1 day and 7 day share price returns of a 2.25% decline and a 5.33% decline suggest some caution is creeping in. However, the 90 day share price return of 4.10% and 1 year total shareholder...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Playtika Holding (PLTK) Valuation Check After Strong Q4 Results And Optimistic 2026 Outlook

Playtika Holding (PLTK) is back in focus after its Q4 2025 earnings update, which highlighted stronger direct to consumer traction and a detailed 2026 outlook that several analysts responded to with refreshed coverage. See our latest analysis for Playtika Holding. The recent Q4 2025 earnings, direct-to-consumer growth, and 2026 guidance have come against a weak backdrop, with a 90-day share price return showing a 31.13% decline and a 1-year total shareholder return showing a 34.74% decline,...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

A Look At ANI Pharmaceuticals (ANIP) Valuation After Earnings Beat And Cortrophin Gel Growth Plan

What ANI’s latest earnings tell you about the business ANI Pharmaceuticals (ANIP) drew investor attention after reporting fourth quarter and full year 2025 results that topped analyst expectations, alongside a clear rare disease growth plan built around Cortrophin Gel and a more cautious full year outlook. For the fourth quarter of 2025, ANI Pharmaceuticals reported sales of US$247.06 million compared with US$190.57 million a year earlier, while net income came in at US$27.49 million versus a...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

A Look At Enliven Therapeutics (ELVN) Valuation After Positive ENABLE Trial Progress And Phase 3 Plans

Enliven Therapeutics (ELVN) has drawn fresh attention after reporting positive initial Phase 1b ENABLE trial data for ELVN-001 in difficult to treat chronic myeloid leukemia, alongside plans to move into a pivotal Phase 3 program. See our latest analysis for Enliven Therapeutics. At a share price of $29.29, Enliven’s recent pullback, with a 1 day share price return of 2.30% decline and 7 day share price return of 1.11% decline, sits against a much stronger backdrop. This includes a 30 day...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage (MNST) Is Down 11.5% After Earnings Beat And New Regional CEOs Announced – Has The Bull Case Changed?

In late February 2026, Monster Beverage Corporation reported fourth-quarter 2025 results showing sales of US$2,131.05 million and net income of US$449.19 million, alongside leadership changes that installed new regional CEOs for the Americas and EMEA & OSP and a new Chief Strategy Officer. Full-year 2025 sales of US$8,294.34 million and net income of US$1,905.43 million, coupled with earnings that outpaced analyst expectations and strong international contributions, have reinforced Monster’s...
NYSE:LEA
NYSE:LEAAuto Components

Is It Too Late To Consider Buying Lear (LEA) After A 32% One Year Rally

If you are wondering whether Lear's current share price still offers value or if the opportunity has already passed you, this article will help you make sense of where the stock stands today. The shares last closed at US$121.97, with returns of 2.0% over the past 30 days, 2.8% year to date and 32.3% over the past year, although the stock has seen an 8.3% decline in the last week. These moves are drawing fresh attention to Lear as investors reassess the stock and look for long term drivers...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Is It Time To Reassess Aurinia Pharmaceuticals (AUPH) After Its 80% One-Year Share Price Jump?

If you are wondering whether Aurinia Pharmaceuticals at around US$14.74 is offering real value or just reflecting hype, you are in the right place to unpack what the current price actually implies. The stock has had a mixed run recently, with a 5.5% gain over the last 7 days, a 3.1% decline over 30 days, a 4.0% decline year to date and an 80.0% return over the past year, which can change how investors think about both upside and risk. Recent news coverage has focused on Aurinia...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Is It Time To Reassess Nextpower (NXT) After A 146% One Year Rally?

If you are wondering whether Nextpower's share price still offers value after a strong run, this article walks through what the current market price might be implying about the company. The stock last closed at US$103.41, with a 3.2% decline over the past week and a 13.7% decline over the past month, but it is still up 11.5% year to date and 145.7% over the past year. These moves can change how investors think about risk and reward. Recent coverage of Nextpower has focused on its position...
NasdaqCM:CELH
NasdaqCM:CELHBeverage

Celsius Holdings (CELH) Is Down 19.3% After Profit Slips Despite Surging 2025 Sales Growth

Celsius Holdings, Inc. reported past fourth-quarter 2025 sales of US$721.63 million, more than doubling year-on-year, and swung from a net loss to a US$24.74 million net profit, while also completing a US$39.8 million buyback of 932,519 shares announced in November 2025. Despite full-year 2025 sales rising to US$2.52 billion from US$1.36 billion, net income fell to US$108 million from US$145.07 million, highlighting the tension between rapid top-line expansion and the cost and margin...
NYSE:BW
NYSE:BWElectrical

Babcock & Wilcox (BW) Turns Q4 Profit From Continuing Operations Testing Bearish Loss Narratives

Babcock & Wilcox Enterprises (BW) just wrapped up FY 2025 with fourth quarter revenue of US$138.8 million, basic EPS of US$0.34 and earnings from discontinued operations of US$19.7 million. Over the past six quarters, revenue has ranged from US$138.8 million to US$200.8 million and basic EPS has moved between a loss of US$0.90 on a trailing 12 month view and a quarterly profit of US$0.34. This underscores how much the earnings line still swings around. For investors, the headline is that...
NasdaqGS:LI
NasdaqGS:LIAuto

Assessing Li Auto (NasdaqGS:LI) Valuation After Recent Share Price Weakness

Event driven snapshot of Li Auto Li Auto (NasdaqGS:LI) shares most recently closed at US$16.88, with the stock showing negative returns over the past week, month and past 3 months as investors reassess the China based electric vehicle maker. See our latest analysis for Li Auto. The recent pullback, including a 2.03% one day share price decline and weaker short term share price returns, sits against a much steeper 1 year total shareholder return loss of 38.75%. This suggests momentum has been...
NYSE:ALL
NYSE:ALLInsurance

Allstate Data Privacy Lawsuit Puts Telematics Strategy And Returns Under Review

A U.S. District Judge has allowed a class action lawsuit against Allstate to proceed. The suit alleges Allstate collected and used driver behavior data from cellphones without proper consent. Plaintiffs claim the company adjusted premiums, denied coverage, and shared data with other insurers. Alleged violations include the Federal Wiretap Act and Fair Credit Reporting Act. For investors watching Allstate (NYSE:ALL), this case puts data practices and customer trust under a spotlight. The...
NYSE:DLR
NYSE:DLRSpecialized REITs

Is Digital Realty’s Lisbon Subsea Hub Reshaping The Investment Case For Digital Realty Trust (DLR)?

Digital Realty has already expanded into Portugal by acquiring a Lisbon data center capable of supporting up to 2.4 MW of IT load, positioned near major subsea cable landings that link Europe with the Americas, Africa, the Middle East, and Asia. This move makes Lisbon a central pillar of Digital Realty’s Southern European platform, enhancing low-latency interconnection across the Iberian Peninsula and reinforcing data corridors between Europe, Africa, and the Americas as AI and cloud...
NYSE:BRSL
NYSE:BRSLHospitality

Brightstar Lottery (BRSL) Valuation Check After Recent Share Price Weakness And Mixed Performance Metrics

Brightstar Lottery stock reacts to recent performance metrics Brightstar Lottery (BRSL) is back on investor radar after recent performance figures highlighted a mixed picture, with shares at $13.65 and total return over the past 3 months showing an 8.9% decline. See our latest analysis for Brightstar Lottery. Brightstar Lottery’s share price has pulled back over recent months, with a 30 day share price return of a 3.74% decline and a 90 day share price return of an 8.88% decline, while the 1...
NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Expands Regulated Base With Multi State Acquisitions

California Water Service Group (NYSE:CWT) is acquiring Nexus Water Group's Nevada and Oregon operations and plans to acquire seven Texas utilities. The deals will add around 36,000 new residential connections to its regulated system footprint. The company is expanding its presence beyond its core California markets into additional western and southern states. California Water Service Group, trading at $45.78, is taking a clear step to grow its regulated utility base outside California. For...
NYSE:WHR
NYSE:WHRConsumer Durables

Assessing Whirlpool (WHR) Valuation As Tepper Targets Recapitalization And Capital Allocation Choices

Whirlpool (WHR) is under sharp scrutiny after activist investor David Tepper criticized management over fresh equity and preferred offerings that are being used to support an $800 million recapitalization focused on debt reduction, automation and vertical integration. See our latest analysis for Whirlpool. The recapitalization and Tepper’s criticism come after a sharp reset in sentiment, with Whirlpool’s 30 day share price return of 28.39% and 1 year total shareholder return of 30.99% both...
NYSE:OMF
NYSE:OMFConsumer Finance

Is There Now An Opportunity In OneMain Holdings (OMF) After Recent Share Price Weakness

If you are wondering whether OneMain Holdings is priced attractively right now, this article will walk through what the current share price could mean for value focused investors. The stock closed at US$55.02 most recently, with returns of 20.3% over 1 year, 78.4% over 3 years and 55.7% over 5 years. Shorter term moves have been weaker, with a 4.8% decline over 7 days, 14.2% over 30 days and 20.3% year to date. Recent headlines around consumer credit conditions and interest rate expectations...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Does Mixed Q4 Results and Reaffirmed WAKIX Guidance Change The Bull Case For Harmony Biosciences (HRMY)?

Harmony Biosciences Holdings, Inc. has reported its fourth-quarter 2025 results, with net income of US$22.49 million, and full-year 2025 net income rising to US$158.69 million, while also reiterating 2026 WAKIX net revenue guidance of US$1.00 billion to US$1.04 billion. The contrast between weaker quarterly earnings per share and higher full-year profit, alongside unchanged WAKIX revenue guidance, gives investors mixed signals on the company’s earnings quality and growth trajectory. We’ll...
NYSE:GLOB
NYSE:GLOBIT

Why Globant (GLOB) Is Up 13.5% After AI Pods-Focused 2026 Outlook And Heavy Buybacks

Globant S.A. recently reported fourth-quarter 2025 results showing sales of US$612.47 million and net income of US$41.56 million, and has been actively repurchasing shares, buying back 820,045 shares for US$49.98 million under its latest program. Alongside these results, the company outlined an AI-focused growth plan centered on its AI Pods subscription model and record bookings, while issuing 2026 revenue guidance that points to modest top-line changes but increased emphasis on recurring,...
NYSE:ANF
NYSE:ANFSpecialty Retail

Abercrombie & Fitch (ANF) Is Down 10.7% After Tempered 2026 Guidance And Major Buyback - Has The Bull Case Changed?

Abercrombie & Fitch Co. recently reported record fiscal 2025 net sales of US$5,266.29 million alongside lower full-year net income of US$506.92 million, while issuing 2026 guidance for 3% to 5% net sales growth, net income per diluted share of US$10.20 to US$11.00, and operating margin of 12.0% to 12.5%. The company paired this tempered growth outlook and expectation of tariff and ERP headwinds with US$450.00 million of share repurchases in 2025, retiring about 11% of its share count and...
NYSE:ETN
NYSE:ETNElectrical

Eaton Taps Insider CFO As Mobility Spinoff And Ultra PCS Deal Advance

Eaton (NYSE:ETN) has appointed David Foster as Chief Financial Officer, marking a key leadership change. The move comes as Eaton prepares a planned spin off of its Mobility business. Foster will also oversee the integration of Ultra PCS Limited into Eaton's operations. Eaton enters this CFO transition with its shares at $354.79 and a 1 year return of 29.5%. Over 3 years the stock has delivered a very large gain, and over 5 years it is up 177.3%. Recent shorter term moves have been softer,...
NYSE:BSX
NYSE:BSXMedical Equipment

How Investors Are Reacting To Boston Scientific (BSX) Expanding Credit Line And Farapulse Indication

On February 26, 2026, Boston Scientific entered into a new US$3.00 billion revolving credit agreement maturing in 2031, adding flexible funding capacity governed by leverage covenants and customary default provisions. This expanded credit line, alongside strong clinical data behind the Farapulse pulsed field ablation platform’s wider CE mark indication, underscores how Boston Scientific is pairing balance sheet flexibility with growth in advanced cardiac therapies. Next, we’ll examine how...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Does Cisco’s First Australian Secure AI Factory With NVIDIA Reshape The Bull Case For Cisco (CSCO)?

In late February 2026, Cisco and SharonAI Holdings announced Australia’s first Cisco Secure AI Factory with NVIDIA, using Cisco UCS servers, Nexus Hyperfabric networking, and 1,024 NVIDIA Blackwell Ultra GPUs alongside VAST Data storage to deliver sovereign, high-performance AI infrastructure aligned with Australia’s National AI Plan. This Secure AI Factory highlights Cisco’s expanding role at the center of secure, AI-optimized data center and networking infrastructure, reinforcing its shift...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Is Ziff Davis (ZD) Pricing Look Interesting After Sharp Weekly Surge And Mixed Valuation Signals

If you are wondering whether Ziff Davis is attractively priced or not, its recent share moves and mixed track record give plenty to think about before you decide what the stock is worth to you. The share price closed at US$43.65 recently, with returns of 57.9% over the past week, 25.4% over the last 30 days, 28.4% year to date, 11.5% over 1 year, and longer term returns of a 42.6% decline over 3 years and a 57.5% decline over 5 years. Recent news flow around Ziff Davis has focused on the...